261/318US=2 / Biol/Mol
Dempsey CE, Roberts DL, Dive C. Bcl-2 family: bax, bak and bid: key mediators of apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 346-78. ISBN 978-3-527-31237-5.

FAMILIA BCL-2; BAX; BAK; BID; MEDIADORES DE APOPTOSE; VIAS MITOCONDRIAIS; CANCER

262/318US=2 / Biol/Mol
Holcik M. IAPs: inhibitor of apoptosis proteins. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 403-26. ISBN 978-3-527-31237-5.

IAPS; INIBIDORES DE PROTEINAS DE APOPTOSE

263/318US=2 / Biol/Mol
Altieri DC. IAPs: targeting the survivin pathway for rational cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 427-42. ISBN 978-3-527-31237-5.

IAPS; SURVIVINA; INIBIDOR DE PROTEINA A APOPTOSE

264/318US=2 / Biol/Mol
Greten FR, Karin M. Survival pathways: nuclear factor-kB in apoptosis and tumorigenesis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 443-61. ISBN 978-3-527-31237-5.

CANCER; FATOR NUCLEAR-KB; APOPTOSE; CARCINOGENESE

265/318US=2 / Biol/Mol
Drexler HCA, Hekman GM, Albert S, Rapp UR. Survival pathways: survival regulation by ras and raf. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 490-513. ISBN 978-3-527-31237-5.

CONTROLE DE SOBREVIVENCIA; RAS; RAF; APOPTOSE

266/318US=2 / Biol/Mol
Speidel D, Deppert W. Oncogenes/tumor suppressor genes: p53-mediated apoptosis: a multifaceted story. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 515-35. ISBN 978-3-527-31237-5.

ONCOGENES; GENES SUPRESSORES DE TUMOR; P53; APOPTOSE MEDIADA

267/318US=2 / Biol/Mol
Chau BN, Bergseid J, Wang JYJ. Oncogenes/tumor suppressor genes: RB and cancer. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 551-67. ISBN 978-3-527-31237-5.

ONCOGENES; GENES SUPRESSORES DE TUMORES; RB; CANCER; APOPTOSE

268/318US=2 / Biol/Mol
Orrenius S, Zhivotovsky B. Modulators: calcium signaling in apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 569-95. ISBN 978-3-527-31237-5.

MODULADORES; SINALIZACAO DE CALCIO; APOPTOSE; MORTE CELULAR

269/318US=2 / Biol/Mol
Lauber K, Wesselborg S. Phagocytosis/clearance: the role of "Eat Me", "Don´t Eat Me" and "Find Me" signals for efficient removal of apoptotic cells. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 623-46. ISBN 978-3-527-31237-5.

FAGOCITOSE; REMOCAO DE CELULAS; APOPTOSE; RESPOSTA POS-FAGOCITOSE; REMOCAO DE CELULAS APOPTOTICAS; AUTOIMUNIDADE

270/318US=2-A / Biol/Mol
Pinkoski MJ. Cellular stress, DNA damage and repair: life and death decisions in response to stress. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 755-76. ISBN 978-3-527-31237-5.

ESTRESSE CELULAR; DANO AO DNA; REPARO DO DNA; MORTE CELULAR; VIAS DE APOPTOSE; SINALIZACAO DE ESTRESSE

271/318US=2-A / Biol/Mol
Kaina B, Roos W. Cellular stress, DNA damage and repair: apoptosis induced by DNA-damaging agents. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 799-821. ISBN 978-3-527-31237-5.

ESTRESSE CELULAR; DANO AO DNA; REPARO DO DNA; APOPTOSE INDUZIDA POR AGENTES; DANIFICACAO DO DNA; P53; CASPASE-2

272/318US=2-A / Biol/Mol
Fulda S, Debatin KM. Molecular targets and therapeutics: therapeutic modulation of apoptosis in cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 847-61. ISBN 978-3-527-31237-5.

METAS MOLECULARES; TERAPEUTICA MOLECULAR; MODULACAO TERAPEUTICA; APOPTOSE; CANCER. TERAPIA

273/318US=2-A / Biol/Mol
Stridh H, Bykov VJN, Selivanova G, Wiman KG. Molecular targets and therapeutics: cancer therapy by reactivation of the p53 apoptosis pathway. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 891-912. ISBN 978-3-527-31237-5.

ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; CANCER. TERAPIA; REATIVACAO DA APOPTOSE; VIA P53; TERAPIA GENETICA

274/318US=2-A / Biol/Mol
Armstrong RC, Belli BA, Deckwerth TL. Molecular targets and therapeutics: small-molecular inhibitors of the of apoptosis proteins. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 913-32. ISBN 978-3-527-31237-5.

ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; INIBIDORES DA PEQUENA MOLECULARES DE PROTEINAS; APOPTOSE

275/318US=2-A / Biol/Mol
Kullmann S, Teichgräber V, Bollinger CR, Gulbins E. Molecular targets and therapeutics: ceramide signaling in apoptosis and cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 997-1013. ISBN 978-3-527-31237-5.

ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; SINALIZACAO DE CERAMIDA; APOPTOSE; CANCER. TERAPIA

276/318US=2-A / Biol/Mol
Rieger J, Weller M. Molecular targets and therapeutics: exploiting apoptosis pathways for glioblastoma therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 1033-48. ISBN 978-3-527-31237-5.

ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; VIAS DE APOPTOSE; GLIOBLASTOMA. TERAPIA; PROTEINA P53; FAMILIA BCL-2; FATOR DE CRESCIMENTO DERIVADO DE PLAQUETAS; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; FOSFOINOSITIDE-3-KINASE

277/318US=2-A / Biol/Mol
Jendrossek V, Belka C. Molecular targets and therapeutics: radiation therapy and apoptosis. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 1049-86. ISBN 978-3-527-31237-5.

ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; RADIOTERAPIA; APOPTOSE; MORTE CELULAR; P53; CERAMIDA; NECROSE

278/318US=36 / Patologia
Schiffer D. Apoptosis. In: ___. Brain tumor pathology: current diagnostic hotspots and pitfalls. The Netherlands: Springer, 2006. p. 171-82. ISBN 978-1-4020-3998-0.

APOPTOSE; CIRCUITO REGULADOR DE OPOPTOSIS; APOPTOSE EM TUMORES CEREBRAIS; EFEITOS SOBRE A APOPTOSE DE TERAPIAS

279/318US=14 / Urologia
Culig Z, Debes JD, Bartsch G, Tindall DJ. Prostate cancer: the role of the androgen receptor in the pathophysiology of prostate cancer. In: Vogelzang NJ, Scardino PT, Shipley WU, Debruyne FMJ, Linehan WM. Comprehensive textbook of genitourinary oncology. 3ª ed. Philadelphia: Lippincott Williams & Wilkins, 2006. p. 31-8. ISBN 978-0-7817-4984-0.

CANCER DE PROSTATA; RECEPTOR ANDROGENO; CANCER DE PROSTATA. FISIOPATOLOGIA; REGULACAO DA TRANSCRICAO; PROTEINAS CO-REGULADORA; APOPTOSE; CICLO CELULAR; ANGIOGENESE; MUTACAO

280/318US=3 / Ginecologia
Lambert PF, Balsitis SJ, Shai A, Simonson SJS, Williams SMG. Transgenic mouse models for the in vivo analysis of papillomavirus oncogene function. In: Campo MS. Papillomavirus research: from natural history to vaccines and beyong. Wymondham: Caister Academic Press, 2006. p. 213-28. ISBN 1-904455-04-2.

PAPILOMAVIRUS HUMANO; HPV; MODELOS DE CAMUNDONGOS TRANSGENICOS; ANALISE IN VIVO; ONCOGENE; ONCOPROTEINA E5; HPV-16 E5; PROTEINA E6; PROTEINA E7; ONCOGENE; APOPTOSE; CANCER CERVICAL; ESTROGENIO; BIOMARCADORES

Primeira | Anterior | Próxima | Última